Table 1.
Variables at Pretest | Control
|
AIM
|
F | p | ||||||
---|---|---|---|---|---|---|---|---|---|---|
DRD4 s alleles (n = 94)
|
DRD4 l alleles (n = 55)
|
DRD4 s alleles (n = 84)
|
DRD4 l alleles (n = 58)
|
|||||||
M | SD | M | SD | M | SD | M | SD | |||
Gender, male | 0.43 | 0.50 | 0.47 | 0.50 | 0.37 | 0.48 | 0.29 | 0.46 | 1.51 | .21 |
SES risk index | 2.05 | 1.48 | 1.93 | 1.45 | 1.99 | 1.33 | 2.26 | 1.24 | 0.64 | .59 |
Family risk | 0.02 | 2.94 | −0.12 | 2.80 | −0.08 | 2.96 | 0.20 | 3.13 | 0.14 | .94 |
Vulnerability cognitions | 0.10 | 2.41 | 0.25 | 2.24 | −0.18 | 1.61 | −0.11 | 1.91 | 0.61 | .61 |
| ||||||||||
n | % | n | % | n | % | n | % | χ2 | p | |
| ||||||||||
Drug use | 3.91 | .69 | ||||||||
No use | 71 | 75.5 | 41 | 74.5 | 63 | 75.0 | 44 | 75.9 | ||
Occasional use | 11 | 11.7 | 8 | 14.5 | 16 | 19.0 | 9 | 15.5 | ||
Regular use | 12 | 12.8 | 6 | 10.9 | 5 | 6.0 | 5 | 8.6 |